Eltrombopag
Back to searchMolecule Structure
Scientific Name
Eltrombopag
Description of the Drug
Eltrombopag is a thrombopoietin receptor agonist used to treat thrombocytopenia or aplastic anemia associated with various etiologies.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06210
http://www.drugbank.ca/drugs/DB06210
Brand Name(s)
Revolade
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Thrombopoietin receptor | SINGLE PROTEIN | AGONIST | CHEMBL1864 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL211081 | ||
DrugBank | DB06210 | ||
PubChem: Thomson Pharma | 14808156 | ||
Nikkaji | J2.645.513H | ||
DrugCentral | 4399 | ||
ChemicalBook | CB71463423 | ||
Guide to Pharmacology | 6961 | ||
rxnorm | ELTROMBOPAG | PROMACTA | ELTROMBOPAG OLAMINE |
ChEBI | 85010 | ||
ZINC | ZINC000011679756 |